DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20194984

Predictors of co-morbidities in chronic obstructive pulmonary disease patients at a tertiary care centre in north India

Kaushlendra Pratap Narayan, S. K. Verma, Surya Kant, R. A. S. Kushwaha, Santosh Kumar, Rajiv Garg, Anand Srivastava, Darshan K. Bajaj, Satyendra Sonkar

Abstract


Background: Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease that is characterised by persistent respiratory symptoms and airflow limitation. COPD is characterised by an intense inflammatory process in the airways, parenchyma, and pulmonary vasculature. It is possible in some cases that the inflammatory process may overflow into the systemic circulation, promoting a generalised inflammatory reaction. Patient with COPD often have concomitant chronic illness (co-morbidities). The aim of this study is to know the pattern of co-morbidities in COPD patients.

Methods: This study was a cross sectional observational study conducted on 172 COPD patients (IPD and OPD) diagnosed on the basis of GOLD guideline 2017. Co morbidities were diagnosed as per standard defined criteria laid down in the respective guidelines.

Results: 55.3% of the patients with COPD had co morbidities. 18/88(20.5%) patients presented with multiple co-morbidities. 49/88, 55.7% COPD patients were affected with cardiac (either only cardiac or had multiple organs affected besides cardiac), the commonest co-morbidity. Amongst cardiac, hypertension and congestive heart failure (CHF) was the commonest (n=19/49, 38.8% each) followed by CAD/CSA/IWMI/IHD/AF. Others were metabolic (n=14/88, 15.9%), GERD (n=13/88, 14.8%), Depression (n=11/88, 12.5%). Less prevalent co-morbidities were Osteoporosis (n=8/88, 9.1%), Lung cancer (n=6/88, 6.8%), Bronchiectasis (n=5/88, 5.6%) and OSA (n=3/88, 3.4%).

Conclusions: Urban indwelling, advancing age and duration of illness, presentation with low mood, loss of pleasure/ interest, appetite disturbances and heart burn with relief on taking proton pump inhibitor can be predictors of co-morbidities in COPD patients. Chance of finding co-morbidities may be multifactorial. Thus, it is important to look out for co morbidities in each and every COPD patients.


Keywords


Co-morbidity, Chronic obstructive pulmonary disease, Predictors of co-morbidities

Full Text:

PDF

References


Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557-82.

Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax.2004;59:574-80.

Barnes PJ, Celli BR. Systemic manifestation and co morbidities of COPD. Eur Respir J. 2009;33:1165-85.

Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison-Himmelfarb CR, et al. Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll of Cardiol. 2017;71(19):e127-e248.

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-80

American Diabetes Association. Diabetes advocacy. Sec. 15. In Standards of Medical Care in Diabetes 2016. Diabetes Care.2017;40:S128-S129.

Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50.

Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017;12(1):43.

Thase ME. Recommendations for Screening for Depression in Adults. JAMA. 2016;315(4):349-50.

Hunt R, Armstrong D, Katelaris P, Afihene M, Bane A, Bhatia S et al. Review Team: World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. J Clin Gastroenterol. 2017;51(6):467-78.

Rivera MP, Mehta AC, and Wahidi MM. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e142S-e165S

Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnoea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(3):479-504.

Dal Negro R, Bonadiman L, Turco P. Prevalence of different co-morbidities in COPD patients by gender and GOLD stage. Multidiscip Respira Medic. 2015;10:24.

Mahishale V, Angadi N, Metgudmath V, Eti A, Lolly M and Khan S. Prevalence and impact of diabetes, hypertension, and cardiovascular diseases in chronic obstructive pulmonary diseases: A hospital-based cross-section study. J Translat Intern Medi. 2015;3:155-160.

Gunaseelan G, Jayaprakash B, Roy N. Period Prevalence of Bronchiectasis in Moderate and Severe COPD. J Medi Sci clini Res. 2017;05:21634-8.

Jorgensen N, Schwarz P, Holme I, Henriksen B, Petersen L, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease - Across sectional study. Resp Medi. 2007;101:177-85.

Hattiholi J, Gaude GS. Prevalence and correlates of osteoporosis in chronic obstructive pulmonary disease patients in India. Lun Ind. 2014;31(3):221-7.

Bhat SA, Mir MM, Koul PA. Osteoporosis in COPD: Are Bones Brittle in COPD? J Pulm Respir Med. 2017;07(04):417.

Chaudhary SC, Nanda S, Tripathi A, Sawlani KK, Gupta KK, Himanshu D et al. Prevalence of psychiatric co-morbidities in chronic obstructive pulmonary disease patients. Lun Ind. 2016;33:174-8.

Xiao T, Qiu H, Chen Y, Zhou X, Wu K, Ruan X et al. Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: a cross-sectional study. BMC Psychi. 2018;18:89.

Bor S, Kitapcioglu G, Solak Z, Ertilav M, Erdinc M. Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease. J Gastroenterol Hepatol. 2010;25:309-13.

Greenberg-Dotan S, Reuveni H, Tal A, Oksenberg A, Cohen A, Shaya FT et al. Increased prevalence of obstructive lung disease in patients with obstructive sleep apnoea. Sle Brea. 2014;18(1):69-75.

Soler X, Gaio E, Powell FL, Ramsdell JW, Loredo JS, Malhotra A et al. High Prevalence of Obstructive Sleep Apnea in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2015;12(8):1219-25.

Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007;176:85-90.